- April 27, 2023
- 9:00 AM - 1:00 PM ET
The recording of the Recombinant Protein-Based COVID-19 Vaccines Workshop is available until Thursday, June 15, 2023. See below for the video.
The Biomedical Advanced Research and Development Authority (BARDA) and FDA are pleased to host a virtual workshop (using Zoom Platform) titled Recombinant Protein-Based COVID-19 Vaccines. The goals of the workshop are to provide: 1) a forum for product sponsors to discuss progress and technical challenges in the manufacturing when changing strain composition to currently circulating variants of SARS-CoV-2; and 2) an open forum for collaborative discussions to facilitate advancement of recombinant protein-based COVID-19 vaccines.
This workshop is a virtual event, held on April 27, 2023, from 9:00 am EDT to 1:00 pm EDT and comprised of external speakers, presentations, and panel discussions with experts in COVID-19 vaccine development from academia, government, and industry.
- United States Government Partners – SARS-CoV-2 epidemiology, need for continuous investment in COVID-19 vaccines including novel and next generation vaccines
- Product Sponsors – Challenges for timely launch of periodic updated vaccines
- Panel Discussion – Overcoming challenges to address strain updates and pandemic readiness.
Topic: Workshop on Recombinant COVID-19 Vaccines
Date: April 27, 2023 9:00 AM Eastern Time (US Canada)
For Further Information Contact:
firstname.lastname@example.org and include the text "Recombinant COVID-19 Workshop" in the subject line.